Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 816 results for "bristol myers squibb"

JGP Global Gestao de Recursos Ltda. Sells 4,203 Shares of Bristol-Myers Squibb Co. (BMY)
WKRB News

KLCM Advisors Inc. Invests $395,000 in Bristol-Myers Squibb Co...

KLCM Advisors Inc. bought a new position in shares of Bristol-Myers Squibb Co. (NYSE:BMY) during the third quarter, Holdings Channel reports. The firm bought 7,335 shares of the biopharmaceutical company's stock, valued at approximately $395,000. ... WKRB News, 50 minutes ago
[x]  

346 images for bristol myers squibb

American Banking News, 1 day ago
Live Trading News, 4 days ago
American Banking News, 1 hour ago
WKRB News, 1 hour ago
Dotemirates.com, 4 days ago
Cancer Therapy Advisor, 1 week ago
World Pharma News, 2 weeks ago
PharmaVOICE, 2 weeks ago
Business Insider, 4 days ago
Yahoo! India, 4 days ago

Cogent Reports: Genentech & Bristol-Myers Squibb Dominate Franchise Image, Overall Engagement Among Oncologists

Genentech and Bristol-Myers Squibb (BMS) lead oncology franchises in image and engagement according to oncologists who give them top scores across multiple metrics. Merck, Novartis, Amgen and Celgene rank in the second tier. In ...
 Minyanville2 hours ago
[x]  
pharmaphorum

BMS to have their cake and eat it with Keytruda settlement

On January 20th, Bristol-Myers Squibb (BMS) and Merck & Co. settled a year-long patent fight over Keytruda (pembrolizumab). BMS claimed that Merck & Co. had infringed BMS and Ono's patents related to the use of program cell death 1 (PD-1) antibodies ...
 Pharmaceutical Technology7 hours ago Bristol Catches A Break At Last  Seeking Alpha1 day ago Merck & Co. Release: Company To Pay $625 Million To Bristol-Myers Squibb In Cancer Patent Row  BioSpace6 hours ago BMS suffers further setback in lung cancer  pharmaphorum1 day ago
[x]  

Exploring Bristol-Myers Squibb's Oncology Segment in 4Q16

Given the strong performance of Opdivo, Bristol-Myers Squibb's (BMY) Oncology segment has emerged as its largest revenue contributor in the last
 Yahoo! Finance7 hours ago How Bristol-Myers Squibb's Oncology Drug Performed in 4Q16  Yahoo! Finance6 hours ago Trends in US New Drug Approvals  Swiss Biotech5 days ago
Motley Fool

Is It Finally OK to Buy Bristol-Myers Squibb?

After reporting disappointing news for its immunotherapy cancer drug Opdivo in lung cancer, Bristol-Myers Squibb's ( NYSE:BMY ) shares have lost one-third of their value. Are they a bargain-basement buy-Read on to learn more about the challenges, ...
 Motley Fool8 hours ago
[x]  

Bristol Myers a takeout target?

"Fast Money" traders Tim Seymour and Guy Adami weigh in on Bristol-Myers Squibb as Jeffries says the company could be an attractive
 Yahoo! Finance23 hours ago

Bristol-Myers: We See Increased Execution Risks

at 11:20 AM EST It's been a tough month for Bristol-Myers Squibb ( BMY ), which has tumbled 16% in It's been a tough month for Bristol-Myers Squibb ( BMY ), which has tumbled 16% in January after announcing that it wouldn't steel accelerated ...
 Marketplace5 hours ago Bristol-Myers: 'We See Increased Execution Risks'  Yahoo! Finance5 hours ago
[x]  
Nasdaq

Bristol-Myers Settles Litigation with Merck for Keytruda

Bristol-Myers Squibb Company BMY along with partner Ono Pharmaceutical Company, Ltd. announced that both the companies have signed a global patent license agreement with Merck & Co., Inc. MRK to settle all patent-infringement litigation related to ...
 Zacks.com22 hours ago
[x]  

I'm Buying Bristol-Myers Squibb Here At 52-Week Lows

Bristol-Myers Squibb (NYSE: BMY ) surprised investors with more disappointing Opdivo related news on Thursday after the bell which sent the stock plummeting more than 11% on Friday. The company announced that it "has decided not to pursue an ...
 Seeking Alpha1 day ago

What's Expected from Bristol-Myers Squibb's 4Q16 Earnings?

With rising sales of innovative products such as Eliquis, Opdivo, and its hepatitis C franchise, Bristol-Myers Squibb is expected to report a rise of over 20% in its
 Yahoo! Finance1 day ago Bristol-Myers Squibb's 4Q16 Estimates: Expect Growth!  Yahoo! Finance9 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less